Contract Research And Manufacturing Services (CRAMS) Market Report 2026

Contract Research And Manufacturing Services (CRAMS) Market Overview

• Contract Research And Manufacturing Services (CRAMS) market size has reached to $155.61 billion in 2025 • Expected to grow to $258.36 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: CRAMS Market Thrives On Ageing Population And Chronic Diseases • Market Trend: AI Revolution In Contract Research And Manufacturing Services (CRAMS) Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Contract Research And Manufacturing Services (CRAMS) Market?

Contract research and manufacturing services (CRAMS) refer to the practice of contracting out product development and research services to businesses that can do so at a reasonable price. It is a procedure whereby the product's parent firm does not actually produce the item themselves. The main types of services provide by contract research and manufacturing services (CRAMS) are manufacturing and research. Manufacturing services include outsourcing drug development services to companies operating in the pharmaceutical or biotechnology industry on a contract basis. The contract manufacturing organizations are involved in the entire development process, right from the clinical trial and phases till the commercialization of the drugs. Research services outsourcing of research services such as clinical trial data management, database design and build, data entry and validation, medicine and disease coding, project management, quality, and metric reporting, safety and efficacy summaries, statistical analysis plans and reports, on a contract basis. The contract research and manufacturing services (CRAMS) are used by pharmaceutical & biotechnology companies, medical device companies, and academic institutes.

What Is The Contract Research And Manufacturing Services (CRAMS) Market Growth Forecast?

The contract research and manufacturing services (crams) market size is expected to see rapid growth in the next few years. It will grow to $258.36 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing adoption of biologics and advanced therapies, expansion of clinical trial outsourcing, growing demand for personalized medicine, technological advancements in manufacturing automation, rising contract manufacturing for medical devices. Major trends in the forecast period include outsourcing of pharmaceutical r&d, expansion of biologics manufacturing services, increasing demand for analytical testing & quality control, growth in custom synthesis & production services, rising adoption of contract manufacturing for medical devices.

Global Contract Research And Manufacturing Services (CRAMS) Market Segmentation

1) By Services: Manufacturing, Research 2) By End User: Pharmaceutical And Biotechnology Companies, Medical Device Companies, Academic Institutes 3) By Product: API (Active Pharmaceutical Ingredient) Services, Finished Dosage Form (FDF) Services, Biologics / Cell & Gene Therapy Services, Formulation Development & Packaging Subsegments: 1) By Manufacturing: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Form (FDF) Manufacturing, Biologics Manufacturing, Contract Manufacturing Of Medical Devices, Formulation Development And Manufacturing, Packaging And Labeling Services, Analytical Testing And Quality Control, Custom Synthesis And Production 2) By Research: Preclinical Research, Clinical Research (Phase I-IV), Drug Discovery And Development Services, Regulatory Affairs And Consulting, Bioanalytical Testing Services, Toxicology Testing, Process Development And Optimization, Clinical Trial Management And Monitoring, Pharmacovigilance And Safety Services

What Is The Driver Of The Contract Research And Manufacturing Services (CRAMS) Market?

The rising ageing population with various chronic diseases is expected to have a positive impact on the growth of the contract research and manufacturing services (CRAMS) market in the forecast period. The world's ageing population is growing rapidly and is expected to continue over the forecast period. With the increase in the geriatric population, the prevalence of various diseases such as cancer, diabetes, Alzheimer’s, arthritis, and other diseases will also rise, and the demand for various drugs or medicines will increase. As a result, the need for contract research and manufacturing services will grow. For instance, in September 2023, according to the Australian Bureau of Statistics, an Australia-based statistical agency, Australia's population, which was 26 million in 2022, is expected to grow to between 34.3 million and 45.9 million by 2071. Additionally, the median age, currently 38.5 years, is projected to rise to between 43.8 and 47.6 years. Therefore, the increasing ageing population will drive the growth of contract research and manufacturing services (CRAMS) industry.

Key Players In The Global Contract Research And Manufacturing Services (CRAMS) Market

Major companies operating in the contract research and manufacturing services (crams) market are Lonza Group, Catalent Inc., WuXi AppTec, Boehringer Ingelheim, Charles River Laboratories, Jubilant Life Sciences, PRA Health Sciences, Syngene International Ltd., Samsung Biologics, Evotec AG, AMRI (Albany Molecular Research Inc.), Parexel International Corporation, ICON plc, IQVIA Holdings Inc., PPD (Pharmaceutical Product Development), Recipharm AB, Curia Global Inc., Cambrex Corporation, Labcorp Drug Development, CordenPharma, Medpace Holdings Inc., FAMAR Health Care Services, Rentschler Biopharma SE, PCI Pharma Services, Dishman Carbogen Amcis Ltd., Thermo Fisher Scientific Inc., ProPharma Group, Siegfried AG

Global Contract Research And Manufacturing Services (CRAMS) Market Trends and Insights

Artificial intelligence (AI) is increasingly being used by the contract research and manufacturing services (CRAMS) market to strengthen its market position. Artificial intelligence is a branch of computer science dealing with the simulation of human behavior in machines. AI can help avoid costly maintenance by predicting when maintenance is needed and supporting the healthcare system. For instance, In June 2024, Medidata, a US-based technology company, launched the Medidata clinical data studio, which specializes in integrating and managing clinical trial data from various sources to improve the efficiency and accuracy of clinical research. It utilizes artificial intelligence to simplify data review and reconciliation, enabling study teams to more effectively detect potential data issues and safety signals. The platform provides a comprehensive workspace for data integration, transformation, and management, allowing users to adopt strong risk-based quality management strategies and access real-time insights.

What Are Latest Mergers And Acquisitions In The Contract Research And Manufacturing Services (CRAMS) Market?

In October 2023, Sterling Pharma Solutions, a UK-based contract development and manufacturing organisation, acquired NewChem Technologies Ltd. for an undisclosed amount. The acquisition aims to enhance Sterling Pharma Solutions' capacity to tackle complex process chemistry challenges and establish itself as the preferred partner and provider of small molecule services to the pharmaceutical industry. NewChem Technologies Ltd. is a UK-based contract research organization.

Regional Insights

North America was the largest region in the contract research and manufacturing services (CRAMS) market in 2025. Asia-Pacific region is expected to grow at a faster pace in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Contract Research And Manufacturing Services (CRAMS) Market?

The contract research and manufacturing services (CRAMS) market includes revenues earned by entities by minimizing cost and focusing on more functional areas. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Contract Research And Manufacturing Services (CRAMS) Market Report 2026?

The contract research and manufacturing services (crams) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the contract research and manufacturing services (crams) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.